Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism

Adverse Events and Mortality in Anticoagulated Patients with Different Categories of Pulmonary Embolism

Objective: To determine whether the pulmonary embolism (PE) categories of massive, submassive, PE with no right ventricle dysfunction (NRVD), and subsegmental only (SSO) adequately predict clinical outcome. Methods: Patients treated for acute PE (March 1, 2013, through July 31, 2019) were followed f...

Full description

Bibliographic Details
Main Authors:	Julia C. Cambron, BS, Elias S. Saba, BS, Robert D. McBane, MD, Ana I. Casanegra, MD, Hector R. Villarraga, MD, Damon E. Houghton, MD, Danielle T. Vlazny, PA-C, MS, David Froehling, MD, David Hodge, MS, Lisa G. Peterson, MAN, RN, Dalene M. Bott-Kitslaar, APRN, CNP, Waldemar E. Wysokinski, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2020-06-01
Series:	Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:	http://www.sciencedirect.com/science/article/pii/S2542454820300436

Similar Items

Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes
by: Nichole E. Brunton, et al.
Published: (2021-05-01)

Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations
by: Manila Gaddh, et al.
Published: (2023-10-01)

P1645: IMPACT OF VON WILLEBRAND FACTOR AND ADAMTS13 ON CARDIOVASCULAR COMPLICATIONS AND BLEEDING IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND NORMAL SINUS RHYTHM CONTROLS: 10 YEARS FOLLOW UP.
by: Waldemar Wysokinski, et al.
Published: (2023-08-01)

Von Willebrand Factor and ADAMTS13 as Predictors of Adverse Outcomes in Patients With Nonvalvular Atrial Fibrillation
by: Waldemar E. Wysokinski, MD, PhD, et al.
Published: (2021-03-01)

Evaluation of Changing Vena Cava Filter Use and Inpatient Hospital Mortality from 2016-2019: A Single-Institution Quality Improvement Project
by: Matthew R. Augustine, MD, et al.
Published: (2021-10-01)

In-home Compared With In-Clinic Warfarin Therapy Monitoring in Mechanical Heart Valves: A Population-Based Study
by: Martin van Zyl, MB, ChB, et al.
Published: (2020-10-01)

Venous Thromboembolism Prophylaxis: Need for Continuous Assessment Due to Changes in Risk During the Same Hospitalization
by: Rahul Chaudhary, MD, et al.
Published: (2020-04-01)

Anticoagulation status post radiofrequency ablation in a patient with hepatocellular carcinoma and delayed bleeding event
by: Oladapo Adaramola, MD, et al.
Published: (2020-08-01)

Phlegmasia cerulea dolens of the upper extremity treated with anticoagulation and leech therapy
by: Julian Melchor, BS, et al.
Published: (2023-12-01)

54. Implementation of a Risk-stratified Anticoagulation Protocol Increases Free Flap Success in Thrombophilic Patients With Chronic Lower Extremity Wounds
by: Romina Deldar, MD, et al.
Published: (2022-06-01)

D27. Effect of Postoperative Anticoagulation Regimen on Lower Extremity Free Flap Outcomes
by: Delani Woods, BS, et al.
Published: (2023-04-01)

Risk Stratification and Management of Intermediate-Risk Acute Pulmonary Embolism
by: Nichole Brunton, et al.
Published: (2024-01-01)

Diagnosis and treatment of a biliary fistula to walled-off pancreatic necrosis
by: Erica Park, MD, et al.
Published: (2024-03-01)

Complication Rates in Patients Using Intracavernosal Injection Therapy for Erectile Dysfunction With or Without Concurrent Anticoagulant Use—A Single-Center, Retrospective Pilot Study
by: Kyle A. Blum, MD, MS, et al.
Published: (2022-08-01)

A dedicated anticoagulation clinic does not improve postoperative management of warfarin after total joint arthroplasty
by: Joshua S. Bingham, MD, et al.
Published: (2018-09-01)

Comparison of Ambulatory Quality Measures Between Shared Practice Panels and Independent Practice Panels
by: Adria Whiting, APRN, CNP, et al.
Published: (2023-08-01)

Proximal Tibia and Fibula Fragility Fracture Complicated by Anticoagulation and Demand-Mediated Myocardial Infarction
by: Daniel Mendelson MS, MD, et al.
Published: (2011-05-01)

Evaluation of Beliefs About Hypertension in a General Population
by: Sarah McBane PharmD, CDE, BCPS, et al.
Published: (2011-04-01)

Corrigendum to “Anticoagulation status post radiofrequency ablation in a patient with hepatocellular carcinoma and delayed bleeding event” [Radiol Case Rep 15 (2020) 1381-1385]
by: Oladapo Adaramola, MD, et al.
Published: (2020-10-01)

P1657: CANCER-ASSOCIATED NON-BACTERIAL THROMBOTIC ENDOCARDITIS AFFECTING RIGHT HEART VALVES AS POTENTIAL CAUSE OF PULMONARY EMBOLISM
by: Ewa Wysokinska, et al.
Published: (2023-08-01)

National Physician Survey for Nonvalvular Atrial Fibrillation (NVAF) Anticoagulation Comparing Knowledge, Attitudes and Practice of Cardiologist to PCPs
by: Haseeb Saeed MD, et al.
Published: (2020-10-01)

Usability of an Atrial Fibrillation Anticoagulation Decision-Support Tool
by: Mark L. Wess MD, SM, et al.
Published: (2011-04-01)

Assessing the Necessity of Prolonged VTE Prophylaxis in DIEP Flap Patients: An Analysis of Our 10-year Institutional Experience
by: Hao Huang, BS, et al.
Published: (2021-10-01)

QS5: Extended Venous Thromboembolism Prophylaxis May Not Be Necessary For DIEP Flap Breast Reconstruction
by: Hao Huang, BS, et al.
Published: (2021-07-01)

Implementation of a Stratified Anticoagulation Protocol Increases Lower Extremity Free Tissue Transfer Success in the Setting of Thrombophilia
by: Elizabeth G. Zolper, BS, et al.
Published: (2020-09-01)

Performance of a Prospective Anticoagulation Stratification Algorithm After Liver Transplantation
by: Jorge Sanchez-Garcia, MD, et al.
Published: (2023-03-01)

Expedited surgery in geriatric hip fracture patients taking direct oral anticoagulants is not associated with increased short-term complications or mortality rates
by: Alexander Brown, MD, et al.
Published: (2020-09-01)

The relevance of a suppressor of fused (SUFU) mutation in the diagnosis and treatment of Gorlin syndrome
by: Taylor Ogden, BS, et al.
Published: (2018-03-01)

Prostate Cancer History and Total Hip Arthroplasty: A Matched Cohort Analysis Investigating Venous Thromboembolism and Anticoagulation
by: Keir Johnson, BS, et al.
Published: (2022-10-01)

Does Use of Oral Anticoagulants at the Time of Admission Affect Outcomes Following Hip Fracture
by: Ariana Lott BA, et al.
Published: (2018-03-01)

New Insights into Anticoagulation in Atrial Fibrillation
by: Xiaohan Fan, MD, et al.
Published: (2011-01-01)

Should we Test the Prothrombin Time in Anticoagulated Epistaxis Patients?
by: Michael B. Soyka M.D., et al.
Published: (2013-03-01)

Telemedicine Video Visits for Children with Medical Complexity in a Structured Clinical Complex Care Program
by: Melissa H. Ross BS, et al.
Published: (2020-10-01)

Prevalence of Left Atrial Appendage Thrombus in Patients Anticoagulated With Direct Oral Anticoagulants: Systematic Review and Meta-analysis
by: Wael Alqarawi, MD, et al.
Published: (2021-05-01)

Evaluation of Blood Loss in Conventional vs MAKOplasty Total Knee Arthroplasty
by: Lauren N. Stimson, BS, MD, et al.
Published: (2022-08-01)

Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis
by: Jorge L. Reyes MD, et al.
Published: (2022-12-01)

Building a High-Dose-Rate Prostate Brachytherapy Program With Real-Time Ultrasound-Based Planning: Initial Safety, Quality, and Outcome Results
by: Hong Zhang, MD, PhD, et al.
Published: (2020-05-01)

Artificial Intelligence of Arterial Doppler Waveforms to Predict Major Adverse Outcomes Among Patients Evaluated for Peripheral Artery Disease
by: Robert D. McBane, et al.
Published: (2024-02-01)

Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients
by: Lenar T. Yessayan, MD, MS, et al.
Published: (2022-05-01)

Salto Talaris Fixed-Bearing Total Ankle Arthroplasty: Long-Term Results at a Mean of 10.7 Years
by: Matthew Veale MS, BS, et al.
Published: (2024-01-01)